InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
5,505.00
(
-0.71%
)
US TECH 100
19,000.00
(
-0.94%
)
Dow Jones
40,287.53
(
-0.93%
)
Brent Oil
81.88
(
0.00%
)
Bitcoin
67,374.58
(
0.30%
)
Post# of 43088
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

cowtown jay

Send PM Follow Ignore
Followers 87
Posts 6743
Boards Moderated 1
Alias Born 09/18/2009

cowtown jay

Re: None

Thursday, 04/04/2024 9:40:39 AM

Thursday, April 04, 2024 9:40:39 AM

Post# of 43088
Sanofi filed an S-8 securities Registration Statement today. I think Sanofi may be our most-tenured shareholder, and that their oncology market could be enhanced by lenzilumab, such as we have seen in CMML. Sanofi previously announced plans to spin-off their healthcare sector, and I am excited about the partnership opportunity this could provide to Humanigen/Taran.

https://www.sec.gov/Archives/edgar/data/1121404/000119312524086673/d803515ds8.htm

The filing notes that, "The information required by Item 1 and Item 2 of Part I of Form S-8 is omitted from this filing..."

The type of information withheld, if I am reading the prospectus instructions correctly, can be found on pages 5-7 in the following link.

https://www.sec.gov/files/forms-8.pdf
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up